K871697

Substantially Equivalent

GENESIS II

Applicant: Biosound, Inc.
Product code: DXK
Advisory panel: Cardiovascular
Date received: 1987-04-30
Decision date: 1987-11-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.